Literature DB >> 7645846

Characterization of T-cell receptor V beta usage in the brain of a subject with multiple sclerosis.

R Shimonkevitz1, R Murray, B Kotzin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7645846     DOI: 10.1111/j.1749-6632.1995.tb44527.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection.

Authors:  E L Oleszak; W L Lin; A Legido; J Melvin; H Hardison; B E Hoffman; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

3.  Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.

Authors:  E Colombo; K Banki; A H Tatum; J Daucher; P Ferrante; R S Murray; P E Phillips; A Perl
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 4.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.